Shenzhen, China, Aug. 21, 2025 (GLOBE NEWSWIRE) -- The school year is right around the corner, and that means new classes, fresh supplies, and maybe even a new backpack or laptop. But along with the excitement comes the challenge of keeping track of your essentials—especially in the hustle of daily school life. That's where MiLi steps in. To kick off the new season, we're celebrating with a Back to School Sale you won't want to miss: 20% off sitewide on our latest tracking innovations. Whether you're a stud ...

Jiangsu, China , Aug. 21, 2025 (GLOBE NEWSWIRE) -- To understand a nation's culture, start by looking at its architecture — those solid structures standing on the land conceal the most vivid historical memories and philosophical codes. Recently, the ten-episode micro-documentary series Architecture of China (Season 1) was officially released. Taking iconic structures in China's Jiangsu region as its starting point, it opens a window for global audiences to closely experience Chinese culture. Here, every bri ...

About BTCS: SILVER SPRING, Md. and NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- BTCS Inc. (Nasdaq: BTCS) ("BTCS" or the "Company"), a blockchain technology-focused company, short for Blockchain Technology Consensus Solutions, and Equity Stock Transfer, LLC ("EST"), a fully independent SEC registered transfer agent, announced a strategic collaboration to deliver a first-of-its-kind blockchain dividend, or "Bividend", of $0.05 per share and a one-time loyalty payment of $0.35 per share, both payable in Ethereu ...

RYE, N.Y., Aug. 21, 2025 (GLOBE NEWSWIRE) -- The Board of Trustees of The Gabelli Global Small and Mid Cap Value Trust (NYSE:GGZ) (the “Fund”) declared a $0.16 per share cash distribution payable on September 23, 2025 to common shareholders of record on September 16, 2025. The Fund intends to pay a quarterly distribution of an amount determined each quarter by the Board of Trustees. In addition to the quarterly distributions, and in accordance with the minimum distribution requirements of the Internal Reven ...

RYE, N.Y., Aug. 21, 2025 (GLOBE NEWSWIRE) -- The Board of Trustees of The Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) (the “Fund”) declared a $0.17 per share cash distribution which will be payable on September 23, 2025 to common shareholders of record on September 16, 2025. The Fund intends to pay a quarterly distribution of an amount determined each quarter by the Board of Trustees. In addition to the quarterly distributions, and in accordance with the minimum distribution requirements of the Interna ...

RYE, N.Y., Aug. 21, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of The Gabelli Multimedia Trust Inc. (NYSE:GGT) (the “Fund”) approved the continuation of its policy of paying fixed monthly cash distributions. The Board of Directors declared cash distributions as set forth below for each of October, November, and December 2025. Distribution MonthRecord DatePayable DateDistribution Per ShareOctoberOctober 17, 2025October 24, 2025$0.07NovemberNovember 13, 2025November 20, 2025$0.07DecemberDecember 12, 2025 ...

Exclusive community offers single-family homes with access to luxurious amenities in sought-after Forsyth CountyCUMMING, Ga., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE: TOL), the nation’s leading builder of luxury homes, today announced the opening of its new model homes at Willow Glen, located in esteemed Forsyth County, Georgia. Willow Glen offers single-family homes on expansive home sites in an exclusive, intimate setting. The brand new Hedgewood and Peterson model homes are now open d ...

Core Viewpoint - Krystal Biotech, Inc. is advancing the development of KB707, a redosable immunotherapy targeting non-small cell lung cancer (NSCLC), with promising early efficacy data leading to an End of Phase 2 meeting with the FDA to discuss registration pathways [1][2][3] Group 1: Development Plans and Efficacy - The company has observed a 36% objective response rate in heavily pre-treated NSCLC patients as of April 15, 2025, with no Grade 4 or 5 adverse events reported, indicating a favorable safety profile [3] - Enrollment is ongoing in the KYANITE-1 study, a Phase 1/2 trial evaluating inhaled KB707 in patients with locally advanced or metastatic lung tumors [4] - The company has paused enrollment in the OPAL-1 study, which evaluates intratumoral KB707, to prioritize inhaled KB707, while continuing to monitor patients in OPAL-1 [5] Group 2: Company Overview - Krystal Biotech is a commercial-stage biotechnology company focused on genetic medicines for diseases with high unmet medical needs, with its first product, VYJUVEK, being the first redosable gene therapy approved in multiple regions [6]

MEDIA CONTACT: Angela Waugaman (703)714-0644 Angela_Waugaman@FreddieMac.com A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a6131666-c5a7-4f22-94d7-3a4590d5bf0c U.S. weekly average mortgage MCLEAN, Va., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Freddie Mac (OTCQB: FMCC) today released the results of its Primary Mortgage Market Survey (PMMS), showing the 30-year fixed-rate mortgage (FRM) averaged 6.58%. "The 30-year fixed-rate mortgage remained flat this wee ...

Árshlutareikningur Sláturfélag Suðurlands jan. – jún. 2025 Reykjavík, 21. ágúst 2025. Fréttatilkynning frá Sláturfélagi Suðurlands svf. Afkoma á fyrri árshelmingi 2025 Tekjur á fyrri árshelmingi 10.131 m.kr. og hækka um 9,4% milli ára694 m.kr. hagnaður á fyrri árshelmingi ársins en 613 m.kr. hagnaður árið áðurEBITDA afkoma var 1.159 m.kr. en 1.103 m.kr. árið áðurEigið fé 8.880 m.kr. í lok júní og eiginfjárhlutfall 60% Árshlutareikningurinn samanstendur af árshlutareikningi Sláturfélags Suðurlands svf. og dó ...